InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the detailed record of transactions filed by Macias William L., Directeur Médical. Director active across 1 companies, notably Immunovant, Inc.. Aggregated, 7 disclosures have been recorded. Total volume traded: €400k. The latest transaction was disclosed on 19 April 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
€6,4221,392 shares@ €4.61350.0001% mcap1.6% of flow
Common Stock
SEC:0001764013-22-000039:0·
€196,75626,813 shares@ €7.33810.0035% mcap100.0% of flow
Common Stock
SEC:0001764013-22-000004·
€196,75626,813 shares@ €7.33810.0035% mcap49.2% of flow
Common Stock
SEC:0001764013-22-000004:0·
0112,108 shares0
Common Stock
SEC:0001764013-21-000121·
0112,108 shares0
Common Stock
SEC:0001764013-21-000121:0·
018,674 shares0
Common Stock
SEC:0001764013-21-000056·
018,674 shares0
Common Stock
SEC:0001764013-21-000056:0·
7 of 7 declarations
About Macias William L.
Macias William L. is the Chief Medical Officer of Immunovant, Inc. He is responsible for leading the company's medical and clinical initiatives. His role is crucial for the development of new treatments and ensuring compliance with medical regulations. William brings significant expertise in the medical field, contributing to Immunovant, Inc.'s mission to provide innovative solutions.
